305 related articles for article (PubMed ID: 17371847)
1. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.
Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847
[TBL] [Abstract][Full Text] [Related]
2. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?
Basbous J; Jariel-Encontre I; Gomard T; Bossis G; Piechaczyk M
Biochimie; 2008 Feb; 90(2):296-305. PubMed ID: 17825471
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity.
Gruda MC; Kovary K; Metz R; Bravo R
Oncogene; 1994 Sep; 9(9):2537-47. PubMed ID: 8058317
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
6. Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (fos-related antigen-1) transcription and phosphorylation.
Hurd TW; Culbert AA; Webster KJ; Tavaré JM
Biochem J; 2002 Dec; 368(Pt 2):573-80. PubMed ID: 12197835
[TBL] [Abstract][Full Text] [Related]
7. c-Fos degradation by the ubiquitin-proteasome proteolytic pathway in osteoclast progenitors.
Ito Y; Inoue D; Kido S; Matsumoto T
Bone; 2005 Dec; 37(6):842-9. PubMed ID: 16172035
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla.
Chan SH; Wang LL; Tseng HL; Chan JY
J Hypertens; 2007 Sep; 25(9):1845-61. PubMed ID: 17762649
[TBL] [Abstract][Full Text] [Related]
9. A 19S proteasomal subunit cooperates with an ERK MAPK-regulated degron to regulate accumulation of Fra-1 in tumour cells.
Pakay JL; Diesch J; Gilan O; Yip YY; Sayan E; Kolch W; Mariadason JM; Hannan RD; Tulchinsky E; Dhillon AS
Oncogene; 2012 Apr; 31(14):1817-24. PubMed ID: 21874050
[TBL] [Abstract][Full Text] [Related]
10. Fos family protein degradation by the proteasome.
Gomard T; Jariel-Encontre I; Basbous J; Bossis G; Moquet-Torcy G; Piechaczyk M
Biochem Soc Trans; 2008 Oct; 36(Pt 5):858-63. PubMed ID: 18793151
[TBL] [Abstract][Full Text] [Related]
11. Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1.
Julien M; Khoshniat S; Lacreusette A; Gatius M; Bozec A; Wagner EF; Wittrant Y; Masson M; Weiss P; Beck L; Magne D; Guicheux J
J Bone Miner Res; 2009 Nov; 24(11):1856-68. PubMed ID: 19419315
[TBL] [Abstract][Full Text] [Related]
12. Sphingomyelinase decreases type II collagen expression in bovine articular cartilage chondrocytes via the ERK signaling pathway.
Gilbert SJ; Blain EJ; Duance VC; Mason DJ
Arthritis Rheum; 2008 Jan; 58(1):209-20. PubMed ID: 18163502
[TBL] [Abstract][Full Text] [Related]
13. Molecular interpretation of ERK signal duration by immediate early gene products.
Murphy LO; Smith S; Chen RH; Fingar DC; Blenis J
Nat Cell Biol; 2002 Aug; 4(8):556-64. PubMed ID: 12134156
[TBL] [Abstract][Full Text] [Related]
14. Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition.
Acquaviva C; Brockly F; Ferrara P; Bossis G; Salvat C; Jariel-Encontre I; Piechaczyk M
Oncogene; 2001 Nov; 20(51):7563-72. PubMed ID: 11709728
[TBL] [Abstract][Full Text] [Related]
15. Constitutive hypophosphorylation of extracellular signal-regulated kinases-1/2 and down-regulation of c-Jun in human gastric adenocarcinoma.
Wu WK; Sung JJ; Yu L; Li ZJ; Chu KM; Cho CH
Biochem Biophys Res Commun; 2008 Aug; 373(2):330-4. PubMed ID: 18570890
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity.
Chen RH; Juo PC; Curran T; Blenis J
Oncogene; 1996 Apr; 12(7):1493-502. PubMed ID: 8622865
[TBL] [Abstract][Full Text] [Related]
17. An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry.
Burch PM; Yuan Z; Loonen A; Heintz NH
Mol Cell Biol; 2004 Jun; 24(11):4696-709. PubMed ID: 15143165
[TBL] [Abstract][Full Text] [Related]
18. [Correlative research between ERK1/2 cascade and c-fos expression after hippocampal neuron epileptiform discharge].
Xu ZC; Liu H; Chen YM
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1639-42. PubMed ID: 19035107
[TBL] [Abstract][Full Text] [Related]
19. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.
Meloche S; Pouysségur J
Oncogene; 2007 May; 26(22):3227-39. PubMed ID: 17496918
[TBL] [Abstract][Full Text] [Related]
20. Cellular and viral Fos proteins are degraded by different proteolytic systems.
Acquaviva C; Salvat C; Brockly F; Bossis G; Ferrara P; Piechaczyk M; Jariel-Encontre I
Oncogene; 2001 Feb; 20(8):942-50. PubMed ID: 11314029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
